Literature DB >> 19203772

The use of two-dimension electrophoresis to identify serum biomarkers from patients with dengue haemorrhagic fever.

Ravindran Thayan1, Tan Lian Huat, Lucy Lum Chai See, Christina Phoay Lay Tan, Nor Shahidah Khairullah, Rohana Yusof, Shamala Devi.   

Abstract

Dengue infection is a major public health problem affecting millions of people living in tropical countries. With no suitable vaccines and specific antiviral drugs, treatment for dengue is usually symptomatic and supportive. Early diagnosis and recognition of severe disease is therefore crucial for better management of the patient. Two-dimension electrophoresis was used to identify disease-associated proteins that can be used for diagnosis and as drug targets for treatment. Two markers, identified by mass spectrometry analysis as alpha1-antitrypsin and NS1 proteins were found to be upregulated in dengue fever (DF; n=10) and dengue haemorrhagic fever (DHF; n=10) patients compared with healthy individuals (n=8). Both alpha1-antitrypsin and NS1 proteins were overexpressed two-fold in DHF patients compared with DF patients. Our study suggests that alpha1-antitrypsin and NS1 protein could be used as biomarkers as early indicators of DHF risk among patients with suspected dengue infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19203772     DOI: 10.1016/j.trstmh.2008.12.018

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  8 in total

1.  Molecular classification of outcomes from dengue virus -3 infections.

Authors:  Allan R Brasier; Yingxin Zhao; John E Wiktorowicz; Heidi M Spratt; Eduardo J M Nascimento; Marli T Cordeiro; Kizhake V Soman; Hyunsu Ju; Adrian Recinos; Susan Stafford; Zheng Wu; Ernesto T A Marques; Nikos Vasilakis
Journal:  J Clin Virol       Date:  2015-01-17       Impact factor: 3.168

2.  Serum proteome changes in dengue virus-infected patients from a dengue-endemic area of India: towards new molecular targets?

Authors:  Sandipan Ray; Rajneesh Srivastava; Karnika Tripathi; Vineet Vaibhav; Swati Patankar; Sanjeeva Srivastava
Journal:  OMICS       Date:  2012-08-23

3.  Discovery proteomics and nonparametric modeling pipeline in the development of a candidate biomarker panel for dengue hemorrhagic fever.

Authors:  Allan R Brasier; Josefina Garcia; John E Wiktorowicz; Heidi M Spratt; Guillermo Comach; Hyunsu Ju; Adrian Recinos; Kizhake Soman; Brett M Forshey; Eric S Halsey; Patrick J Blair; Claudio Rocha; Isabel Bazan; Sundar S Victor; Zheng Wu; Susan Stafford; Douglas Watts; Amy C Morrison; Thomas W Scott; Tadeusz J Kochel
Journal:  Clin Transl Sci       Date:  2012-02-23       Impact factor: 4.689

4.  Determination of viremia and concentration of circulating nonstructural protein 1 in patients infected with dengue virus in Mexico.

Authors:  Sergio I de la Cruz-Hernández; Hilario Flores-Aguilar; Silvia González-Mateos; Irma López-Martinez; Celia Alpuche-Aranda; Juan E Ludert; Rosa M del Angel
Journal:  Am J Trop Med Hyg       Date:  2013-01-21       Impact factor: 2.345

5.  Ferritin levels predict severe dengue.

Authors:  R Soundravally; B Agieshkumar; M Daisy; J Sherin; C C Cleetus
Journal:  Infection       Date:  2014-10-30       Impact factor: 7.455

6.  Serum proteome and cytokine analysis in a longitudinal cohort of adults with primary dengue infection reveals predictive markers of DHF.

Authors:  Yadunanda Kumar; Cui Liang; Zheng Bo; Jagath C Rajapakse; Eng Eong Ooi; Steven R Tannenbaum
Journal:  PLoS Negl Trop Dis       Date:  2012-11-29

7.  Isotope Coded Protein Labeling analysis of plasma specimens from acute severe dengue fever patients.

Authors:  Romain Fragnoud; Javier Yugueros-Marcos; Alexandre Pachot; Frederic Bedin
Journal:  Proteome Sci       Date:  2012-10-26       Impact factor: 2.480

Review 8.  Differential expression of serum/plasma proteins in various infectious diseases: specific or nonspecific signatures.

Authors:  Sandipan Ray; Sandip K Patel; Vipin Kumar; Jagruti Damahe; Sanjeeva Srivastava
Journal:  Proteomics Clin Appl       Date:  2013-12-27       Impact factor: 3.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.